| Cytosolic DNA-sensing pathway |
1.93 |
4.58e-2 |
52/63 (82.54%) |
NFKBIA;CXCL10;CCL5;...
|
| Allograft rejection |
1.91 |
2.29e-2 |
32/38 (84.21%) |
HLA-B;HLA-F;FAS;...
|
| Lysosome |
1.91 |
1.53e-2 |
115/128 (89.84%) |
CTSA;GM2A;CTSL;...
|
| Kaposi sarcoma-associated herpesvirus infection |
1.90 |
1.15e-2 |
172/193 (89.12%) |
CDKN1A;TP53;NFKBIA;...
|
| Autoimmune thyroid disease |
1.89 |
9.16e-3 |
46/53 (86.79%) |
HLA-B;HLA-F;FAS;...
|
| Herpes simplex virus 1 infection |
1.88 |
9.55e-3 |
165/498 (33.13%) |
TP53;IFIH1;NFKBIA;...
|
| Graft-versus-host disease |
1.85 |
1.64e-2 |
32/42 (76.19%) |
HLA-B;HLA-F;FAS;...
|
| Basal cell carcinoma |
1.84 |
1.43e-2 |
41/63 (65.08%) |
CDKN1A;DDB2;TP53;...
|
| Influenza A |
1.83 |
1.27e-2 |
156/172 (90.7%) |
MX1;IFIH1;NFKBIA;...
|
| Hepatitis C |
1.83 |
1.15e-2 |
139/157 (88.54%) |
IFIT1;CDKN1A;MX1;...
|
| Epstein-Barr virus infection |
1.78 |
2.60e-2 |
189/202 (93.56%) |
ISG15;CDKN1A;DDB2;...
|
| NOD-like receptor signaling pathway |
1.74 |
2.86e-2 |
145/181 (80.11%) |
NFKBIA;OAS2;OAS1;...
|
| Type I diabetes mellitus |
1.73 |
2.82e-2 |
38/43 (88.37%) |
HLA-B;HLA-F;FAS;...
|
| RIG-I-like receptor signaling pathway |
1.73 |
3.11e-2 |
64/70 (91.43%) |
ISG15;IFIH1;NFKBIA;...
|
| Viral myocarditis |
1.69 |
3.97e-2 |
53/60 (88.33%) |
HLA-B;HLA-F;CD55;...
|
| Measles |
1.67 |
4.37e-2 |
133/139 (95.68%) |
MX1;TP53;IFIH1;...
|
| Human papillomavirus infection |
1.66 |
4.45e-2 |
284/331 (85.8%) |
ISG15;CDKN1A;MX1;...
|
| Melanoma |
1.65 |
4.58e-2 |
68/72 (94.44%) |
CDKN1A;DDB2;TP53;...
|
| Small cell lung cancer |
1.65 |
4.58e-2 |
90/92 (97.83%) |
CDKN1A;DDB2;TP53;...
|
| Endometrial cancer |
1.65 |
4.47e-2 |
56/58 (96.55%) |
CDKN1A;DDB2;TP53;...
|
| Inflammatory bowel disease |
1.64 |
4.96e-2 |
58/65 (89.23%) |
SMAD3;STAT1;STAT6;...
|
| Arginine and proline metabolism |
-1.57 |
4.70e-2 |
39/50 (78%) |
GOT1;NOS2;MAOA;...
|
| Non-homologous end-joining |
-1.57 |
4.62e-2 |
11/13 (84.62%) |
NHEJ1;XRCC5;DCLRE1C;...
|
| Spinocerebellar ataxia |
-1.58 |
4.76e-2 |
128/143 (89.51%) |
PSMA4;PSMC5;GRIN2B;...
|
| Porphyrin and chlorophyll metabolism |
-1.58 |
4.84e-2 |
23/43 (53.49%) |
CPOX;UGT2B17;ALAS2;...
|
| Protein export |
-1.59 |
4.70e-2 |
17/23 (73.91%) |
SEC61G;SRP9;SPCS3;...
|
| Base excision repair |
-1.60 |
4.33e-2 |
29/33 (87.88%) |
MBD4;POLE3;POLE;...
|
| Neomycin, kanamycin and gentamicin biosynthesis |
-1.61 |
4.40e-2 |
5/5 (100%) |
HKDC1;HK1;HK2
|
| N-Glycan biosynthesis |
-1.63 |
3.81e-2 |
38/50 (76%) |
DDOST;MOGS;DOLPP1;...
|
| Glyoxylate and dicarboxylate metabolism |
-1.64 |
3.30e-2 |
23/30 (76.67%) |
PGP;ACO2;GLUL;...
|
| Homologous recombination |
-1.66 |
2.96e-2 |
35/41 (85.37%) |
BLM;RPA3;TOPBP1;...
|
| One carbon pool by folate |
-1.68 |
2.63e-2 |
15/20 (75%) |
GART;TYMS;ATIC;...
|
| Amino sugar and nucleotide sugar metabolism |
-1.70 |
1.83e-2 |
38/48 (79.17%) |
AMDHD2;GFPT1;HKDC1;...
|
| Galactose metabolism |
-1.71 |
1.63e-2 |
26/31 (83.87%) |
G6PC3;AKR1B1;B4GALT2;...
|
| Arginine biosynthesis |
-1.74 |
1.46e-2 |
17/22 (77.27%) |
GLS2;ASL;GLUL;...
|
| Cysteine and methionine metabolism |
-1.77 |
1.26e-2 |
43/50 (86%) |
AHCYL2;DNMT3A;MDH2;...
|
| RNA transport |
-1.80 |
1.12e-2 |
128/186 (68.82%) |
RPP14;EIF2B1;EIF2S1;...
|
| Spliceosome |
-1.84 |
9.29e-3 |
101/150 (67.33%) |
PRPF19;PQBP1;HNRNPA1;...
|
| Mismatch repair |
-1.93 |
5.42e-3 |
22/23 (95.65%) |
RFC1;RPA3;LIG1;...
|
| Protein processing in endoplasmic reticulum |
-2.03 |
1.63e-3 |
127/171 (74.27%) |
DERL2;MAN1A1;RPN2;...
|
| Cell cycle |
-2.10 |
2.03e-3 |
110/124 (88.71%) |
CUL1;CCND2;BUB3;...
|
| Oocyte meiosis |
-2.13 |
0.00e+0 |
90/129 (69.77%) |
PPP1CC;CAMK2B;ANAPC10;...
|
| Progesterone-mediated oocyte maturation |
-2.27 |
0.00e+0 |
75/100 (75%) |
PIK3R2;FZR1;MAD1L1;...
|
| DNA replication |
-2.43 |
0.00e+0 |
34/36 (94.44%) |
SSBP1;POLE3;POLE;...
|
